AstraZeneca PLC (NYSE:AZN)

During the Trading Day
73.05 -0.14 / -0.19%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
73.04 -0.01 / -0.01%
 
Volume: 11.5K
AstraZeneca Updates on PLATO Study Investigation on Brilinta - Analyst Blog
5:47pm / Zacks.com
Novo Nordisk to Pay Fine, Tresiba in Focus - Analyst Blog
Aug 19 / Zacks.com
Lannett Updates on Digoxin Safety Issues, Expands Portfolio - Analyst Blog
5:30pm / Zacks.com
Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog
Aug 19 / Zacks.com
Ampio Shares Fall as STEP Study on Ampion Gets Delayed - Analyst Blog
5:13pm / Zacks.com
Eli Lilly-Boehringer's Insulin Drug Gets Tentative FDA Nod - Analyst Blog
Aug 19 / Zacks.com
3 Reasons Bristol-Myers Squibb's Stock Could Rise
4:48pm / MotleyFool.com
How Will AstraZeneca (AZN) Stock Respond To U.S. Clearing Heart Drug Trial?
Aug 19 / TheStreet.com
Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole
Aug 21 / Benzinga
AstraZeneca's Asthma Drug in Focus, Phase III Study Initiated - Analyst Blog
Aug 18 / Zacks.com
GlaxoSmithKline's (GSK) Arnuity Ellipta Approved by FDA - Analyst Blog
Aug 21 / Zacks.com
Mallinckrodt Acquires Questcor, to Join S&P 500 As Well - Analyst Blog
Aug 18 / Zacks.com
Actavis Up on Positive Phase III Ceftazidime-Avibactam Data - Analyst Blog
Aug 21 / Zacks.com
Roche's Avastin Approved by FDA for Advanced Cervical Cancer - Analyst Blog
Aug 18 / Zacks.com
Illumina Partners with AstraZeneca, Sanofi, Janssen in NGS - Analyst Blog
Aug 21 / Zacks.com
AstraZeneca's Gout Drug in Focus with Phase III Data Readout - Analyst Blog
Aug 15 / Zacks.com
Pfizer Could Revive AstraZeneca Bid As Early As Tuesday
Aug 21 / Benzinga
Pfizer's Prevnar 13 Backed by U.S. Panel for Expanded Use - Analyst Blog
Aug 14 / Zacks.com
Why AstraZeneca (AZN) Stock Is Higher Today
Aug 21 / TheStreet.com
Merck's Insomnia Drug Belsomra Approved by the FDA - Analyst Blog
Aug 14 / Zacks.com
Pre-Market Activity Shows Gains For AstraZeneca (AZN)
Aug 21 / TheStreet.com
Dynavax Technologies Q2 Loss Wider than Expected, Sales Beat - Analyst Blog
Aug 08 / Zacks.com
Sanofi's (SNY) Cerdelga FDA Approved for Gaucher Disease - Analyst Blog
Aug 20 / Zacks.com
Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales - Analyst Blog
Aug 08 / Zacks.com
Ampio's Ampion Positive in Open Label Study, Shares Up - Analyst Blog
Aug 20 / Zacks.com
OncoGenex Q2 Loss Narrower than Expected, Revenues Down Y/Y - Analyst Blog
Aug 08 / Zacks.com
Oncothyreon (ONTY) Slumps, Tecemotide Fails Phase I/II Study - Analyst Blog
Aug 20 / Zacks.com
How to stay safe in a scary market
Aug 07 / CNNMoney.com
Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Analyst Blog
Aug 19 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.